Amanda A Allshouse1, Alex Polotsky, Sybil Crawford, Hsiang-Yu Chen, Samar R El Khoudary, Nanette Santoro. 1. From the 1Department of Biostatistics and Informatics, School of Public Health, and 2Department of Obstetrics and Gynecology, University of Colorado Denver, Aurora, CO; 3Department of Epidemiology, Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, MA; and 4Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Abstract
OBJECTIVE: This study aims to test the hypothesis that consistently ovulatory premenopausal/perimenopausal women have a more favorable cardiometabolic profile than anovulatory women. METHODS: The first four collections from the Study of Women's Health Across the Nation Daily Hormone Study (DHS) were used. DHS enrollees annually completed a daily collection of first morning voided urine for an entire menstrual cycle or up to 50 days (whichever comes first). A woman was categorized as consistently ovulatory annually (COA) if four ovulatory cycles or two to three ovulatory cycles followed by the final menstrual period (FMP) were observed. A woman was categorized as not consistently ovulatory annually (nCOA) if at least one anovulatory year was observed. Cross-sectional and longitudinal differences were compared between COA and nCOA women. Data were centered at FMP and adjusted for age and body mass index (BMI). RESULTS: Six hundred thirty-six DHS participants (mean [SD] age, 47.3 [2.5] y; mean [SD] BMI, 27.4 [7.1] kg/m(2)) were included. Thirty-six percent of the DHS participants were COA women. On the fourth follow-up collection, COA women had lower high-density lipoprotein than nCOA women (mean [95% CI], 55.7 [54.0-57.4] vs 59.5 [57.9-61.0] mg/dL, P = 0.002, respectively), which persisted after adjustment. Among 460 women with FMP, 39% were COA women. COA women were slightly older (52.9 vs 52.0 y, P = 0.002) and had lower BMI (geometric mean, 26.1 vs 27.5 kg/m(2), P = 0.06) than nCOA women at FMP. Other cardiometabolic factors did not significantly differ by COA status through FMP. CONCLUSIONS: Consistent ovulation across the menopausal transition does not seem to reflect superior cardiometabolic health.
OBJECTIVE: This study aims to test the hypothesis that consistently ovulatory premenopausal/perimenopausal women have a more favorable cardiometabolic profile than anovulatory women. METHODS: The first four collections from the Study of Women's Health Across the Nation Daily Hormone Study (DHS) were used. DHS enrollees annually completed a daily collection of first morning voided urine for an entire menstrual cycle or up to 50 days (whichever comes first). A woman was categorized as consistently ovulatory annually (COA) if four ovulatory cycles or two to three ovulatory cycles followed by the final menstrual period (FMP) were observed. A woman was categorized as not consistently ovulatory annually (nCOA) if at least one anovulatory year was observed. Cross-sectional and longitudinal differences were compared between COA and nCOA women. Data were centered at FMP and adjusted for age and body mass index (BMI). RESULTS: Six hundred thirty-six DHSparticipants (mean [SD] age, 47.3 [2.5] y; mean [SD] BMI, 27.4 [7.1] kg/m(2)) were included. Thirty-six percent of the DHSparticipants were COA women. On the fourth follow-up collection, COA women had lower high-density lipoprotein than nCOA women (mean [95% CI], 55.7 [54.0-57.4] vs 59.5 [57.9-61.0] mg/dL, P = 0.002, respectively), which persisted after adjustment. Among 460 women with FMP, 39% were COA women. COA women were slightly older (52.9 vs 52.0 y, P = 0.002) and had lower BMI (geometric mean, 26.1 vs 27.5 kg/m(2), P = 0.06) than nCOA women at FMP. Other cardiometabolic factors did not significantly differ by COA status through FMP. CONCLUSIONS: Consistent ovulation across the menopausal transition does not seem to reflect superior cardiometabolic health.
Authors: Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa Journal: Circulation Date: 2005-09-12 Impact factor: 29.690
Authors: Leslee J Shaw; C Noel Bairey Merz; Carl J Pepine; Steven E Reis; Vera Bittner; Sheryl F Kelsey; Marian Olson; B Delia Johnson; Sunil Mankad; Barry L Sharaf; William J Rogers; Timothy R Wessel; Christopher B Arant; Gerald M Pohost; Amir Lerman; Arshed A Quyyumi; George Sopko Journal: J Am Coll Cardiol Date: 2006-02-07 Impact factor: 24.094
Authors: N Santoro; S L Crawford; W L Lasley; J L Luborsky; K A Matthews; D McConnell; J F Randolph; E B Gold; G A Greendale; S G Korenman; L Powell; M F Sowers; G Weiss Journal: J Clin Endocrinol Metab Date: 2008-02-19 Impact factor: 5.958
Authors: Carol A Derby; Sybil L Crawford; Richard C Pasternak; Maryfran Sowers; Barbara Sternfeld; Karen A Matthews Journal: Am J Epidemiol Date: 2009-04-08 Impact factor: 4.897
Authors: Nanette Santoro; Sybil L Crawford; Samar R El Khoudary; Amanda A Allshouse; Sherri-Ann Burnett-Bowie; Joel Finkelstein; Carol Derby; Karen Matthews; Howard M Kravitz; Sioban D Harlow; Gail A Greendale; Ellen B Gold; Rasa Kazlauskaite; Dan McConnell; Genevieve Neal-Perry; Jelena Pavlovic; John Randolph; Gerson Weiss; Hsiang-Yu Chen; Bill Lasley Journal: J Clin Endocrinol Metab Date: 2017-07-01 Impact factor: 5.958